-
1
-
-
57249098943
-
The barrier of hypoglycemia in diabetes
-
Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
-
(2008)
Diabetes
, vol.57
, pp. 3169-3176
-
-
Cryer, P.E.1
-
2
-
-
0020700793
-
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion
-
Bolli G, de Feo P, Compagnucci P, et al. Abnormal glucose counter-regulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983; 32:134-141 (Pubitemid 13180346)
-
(1983)
Diabetes
, vol.32
, Issue.2
, pp. 134-141
-
-
Bolli, G.1
De Feo, P.2
Compagnucci, P.3
-
3
-
-
0015901935
-
Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect
-
Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973;182:171-173
-
(1973)
Science
, vol.182
, pp. 171-173
-
-
Gerich, J.E.1
Langlois, M.2
Noacco, C.3
Karam, J.H.4
Forsham, P.H.5
-
4
-
-
67650091175
-
Central but not systemic lipid infusion augments the counterregulatory response to hypoglycemia
-
Haywood SC, Bree AJ, Puente EC, Daphna-Iken D, Fisher SJ. Central but not systemic lipid infusion augments the counterregulatory response to hypoglycemia. Am J Physiol Endocrinol Metab 2009;297:E50-E56
-
(2009)
Am J Physiol Endocrinol Metab
, vol.297
-
-
Haywood, S.C.1
Bree, A.J.2
Puente, E.C.3
Daphna-Iken, D.4
Fisher, S.J.5
-
5
-
-
77950805120
-
Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia
-
Zhu W, Czyzyk D, Paranjape SA, et al. Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Am J Physiol Endocrinol Metab 2010;298:E971-E977
-
(2010)
Am J Physiol Endocrinol Metab
, vol.298
-
-
Zhu, W.1
Czyzyk, D.2
Paranjape, S.A.3
-
6
-
-
0344838670
-
Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia
-
discussion 322-323
-
Taborsky GJ Jr, Ahren B, Mundinger TO, Mei Q, Havel PJ. Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia. Diabetes Nutr Metab 2002;15:318-322; discussion 322-323
-
(2002)
Diabetes Nutr Metab
, vol.15
, pp. 318-322
-
-
Taborsky Jr., G.J.1
Ahren, B.2
Mundinger, T.O.3
Mei, Q.4
Havel, P.J.5
-
7
-
-
34250895793
-
Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats
-
DOI 10.1210/en.2006-1375
-
Zhou H, Zhang T, Oseid E, Harmon J, Tonooka N, Robertson RP. Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats. Endocrinology 2007;148:2863-2869 (Pubitemid 46984800)
-
(2007)
Endocrinology
, vol.148
, Issue.6
, pp. 2863-2869
-
-
Zhou, H.1
Zhang, T.2
Oseid, E.3
Harmon, J.4
Tonooka, N.5
Robertson, R.P.6
-
8
-
-
2642593026
-
Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired alpha-cell responses in type 1 diabetes
-
DOI 10.2337/diabetes.47.7.995
-
Taborsky GJ Jr, Ahrén B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 1998;47:995-1005 (Pubitemid 28294539)
-
(1998)
Diabetes
, vol.47
, Issue.7
, pp. 995-1005
-
-
Taborsky Jr., G.J.1
Ahren, B.2
Havel, P.J.3
-
9
-
-
14644439841
-
Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: Documentation of the intraislet insulin hypothesis in humans
-
DOI 10.2337/diabetes.54.3.757
-
Raju B, Cryer PE. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. Diabetes 2005;54:757-764 (Pubitemid 40322079)
-
(2005)
Diabetes
, vol.54
, Issue.3
, pp. 757-764
-
-
Raju, B.1
Cryer, P.E.2
-
10
-
-
0025019740
-
Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: A putative mechanism of glucagon irresponsiveness to hypoglycemia
-
Rastogi KS, Lickley L, Jokay M, Efendic S, Vranic M. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia. Endocrinology 1990;126: 1096-1104 (Pubitemid 20079529)
-
(1990)
Endocrinology
, vol.126
, Issue.2
, pp. 1096-1104
-
-
Rastogi, K.S.1
Lickley, L.2
Jokay, M.3
Efendic, S.4
Vranic, M.5
-
11
-
-
0017065890
-
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes
-
Orci L, Baetens D, Rufener C, et al. Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci USA 1976;73:1338-1342
-
(1976)
Proc Natl Acad Sci USA
, vol.73
, pp. 1338-1342
-
-
Orci, L.1
Baetens, D.2
Rufener, C.3
-
12
-
-
0036084145
-
Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats
-
Inouye K, Shum K, Chan O, Mathoo J, Matthews SG, Vranic M. Effects of recurrent hyperinsulinemia with and without hypoglycemia on counter-regulation in diabetic rats. Am J Physiol Endocrinol Metab 2002;282: E1369-E1379 (Pubitemid 34654707)
-
(2002)
American Journal of Physiology - Endocrinology and Metabolism
, vol.282
, Issue.6
-
-
Inouye, K.1
Shum, K.2
Chan, O.3
Mathoo, J.4
Matthews, S.G.5
Vranic, M.6
-
13
-
-
0029937016
-
Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats
-
DOI 10.1210/en.137.8.3193
-
Shi ZQ, Rastogi KS, Lekas M, Efendic S, Drucker DJ, Vranic M. Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats. Endocrinology 1996;137:3193-3199 (Pubitemid 26250163)
-
(1996)
Endocrinology
, vol.137
, Issue.8
, pp. 3193-3199
-
-
Shi, Z.Q.1
Rastogi, K.S.2
Lekas, M.3
Efendic, S.4
Drucker, D.J.5
Vranic, M.6
-
14
-
-
0024818826
-
Tissue-specific alterations in somatostatin mRNA accumulation in streptozocin-induced diabetes
-
Papachristou DN, Pham K, Zingg HH, Patel YC. Tissue-specific alterations in somatostatin mRNA accumulation in streptozocin-induced diabetes. Diabetes 1989;38:752-757 (Pubitemid 19285729)
-
(1989)
Diabetes
, vol.38
, Issue.6
, pp. 752-757
-
-
Papachristou, D.N.1
Pham, K.2
Zingg, H.H.3
Patel, Y.C.4
-
15
-
-
0032780823
-
Somatostatin and its receptor family
-
DOI 10.1006/frne.1999.0183
-
Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20:157-198 (Pubitemid 29362641)
-
(1999)
Frontiers in Neuroendocrinology
, vol.20
, Issue.3
, pp. 157-198
-
-
Patel, Y.C.1
-
16
-
-
0034465470
-
Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: An in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice
-
DOI 10.1210/en.141.1.111
-
Strowski MZ, Parmar RM, Blake AD, Schaeffer JM. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 2000;141:111-117 (Pubitemid 32260349)
-
(2000)
Endocrinology
, vol.141
, Issue.1
, pp. 111-117
-
-
Strowski, M.Z.1
Parmar, R.M.2
Blake, A.D.3
Schaeffer, J.M.4
-
17
-
-
0032908805
-
Subtype-selective expression of the five somatostatin receptors (hSSTR1- 5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis
-
DOI 10.2337/diabetes.48.1.77
-
Kumar U, Sasi R, Suresh S, et al. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 1999; 48:77-85 (Pubitemid 29019355)
-
(1999)
Diabetes
, vol.48
, Issue.1
, pp. 77-85
-
-
Kumar, U.1
Sasi, R.2
Suresh, S.3
Patel, A.4
Thangaraju, M.5
Metrakos, P.6
Patel, S.C.7
Patel, Y.C.8
-
18
-
-
0242432598
-
Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats
-
DOI 10.2337/diabetes.52.5.1176
-
Cejvan K, Coy DH, Efendic S. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 2003;52:1176-1181 (Pubitemid 36523353)
-
(2003)
Diabetes
, vol.52
, Issue.5
, pp. 1176-1181
-
-
Cejvan, K.1
Coy, D.H.2
Efendic, S.3
-
19
-
-
0021778416
-
Central nervous system actions of somatostatin-related peptides
-
Brown MR, Fisher LA. Central nervous system actions of somatostatin-related peptides. Adv Exp Med Biol 1985;188:217-228
-
(1985)
Adv Exp Med Biol
, vol.188
, pp. 217-228
-
-
Brown, M.R.1
Fisher, L.A.2
-
20
-
-
0026100430
-
Mechanism of glucoregulatory responses to stress and their deficiency in diabetes
-
Miles PD, Yamatani K, Lickley HL, Vranic M. Mechanism of glucoregulatory responses to stress and their deficiency in diabetes. Proc Natl Acad Sci USA 1991;88:1296-1300 (Pubitemid 21916211)
-
(1991)
Proceedings of the National Academy of Sciences of the United States of America
, vol.88
, Issue.4
, pp. 1296-1300
-
-
Miles, P.D.G.1
Yamatani, K.2
Lickley, H.L.A.3
Vranic, M.4
-
21
-
-
0027990802
-
Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs
-
DOI 10.1016/0026-0495(94)90056-6
-
Miles PD, Yamatani K, Brown MR, Lickley HL, Vranic M. Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs. Metabolism 1994;43:1134-1143 (Pubitemid 24286576)
-
(1994)
Metabolism: Clinical and Experimental
, vol.43
, Issue.9
, pp. 1134-1143
-
-
Miles, P.D.G.1
Yamatani, K.2
Brown, M.R.3
Lickley, H.L.A.4
Vranic, M.5
-
22
-
-
0031791071
-
Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue
-
DOI 10.1038/sj.bjp.0702160
-
Rossowski WJ, Cheng BL, Jiang NY, Coy DH. Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue. Br J Pharmacol 1998;125:1081-1087 (Pubitemid 28495371)
-
(1998)
British Journal of Pharmacology
, vol.125
, Issue.5
, pp. 1081-1087
-
-
Rossowski, W.J.1
Cheng, B.-L.2
Jiang, N.-Y.3
Coy, D.H.4
-
23
-
-
0033519639
-
Highly potent cyclic disulfide antagonists of somatostatin
-
DOI 10.1021/jm9806289
-
Hocart SJ, Jain R, Murphy WA, Taylor JE, Coy DH. Highly potent cyclic disulfide antagonists of somatostatin. J Med Chem 1999;42:1863-1871 (Pubitemid 29269619)
-
(1999)
Journal of Medicinal Chemistry
, vol.42
, Issue.11
, pp. 1863-1871
-
-
Hocart, S.J.1
Jain, R.2
Murphy, W.A.3
Taylor, J.E.4
Coy, D.H.5
-
24
-
-
63249127193
-
Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function
-
Hauge-Evans AC, King AJ, Carmignac D, et al. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009;58:403-411
-
(2009)
Diabetes
, vol.58
, pp. 403-411
-
-
Hauge-Evans, A.C.1
King, A.J.2
Carmignac, D.3
-
25
-
-
33846943674
-
Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: An in vitro study on isolated human pancreatic islets
-
Singh V, Brendel MD, Zacharias S, et al. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. J Clin Endocrinol Metab 2007;92:673-680
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 673-680
-
-
Singh, V.1
Brendel, M.D.2
Zacharias, S.3
-
26
-
-
34047136620
-
2+-channel-evoked CICR regulates glucose-induced somatostatin secretion
-
DOI 10.1038/ncb1563, PII NCB1563
-
Zhang Q, Bengtsson M, Partridge C, et al. R-type Ca(2+)-channel-evoked CICR regulates glucose-induced somatostatin secretion. Nat Cell Biol 2007;9:453-460 (Pubitemid 46511079)
-
(2007)
Nature Cell Biology
, vol.9
, Issue.4
, pp. 453-460
-
-
Zhang, Q.1
Bengtsson, M.2
Partridge, C.3
Salehi, A.4
Braun, M.5
Cox, R.6
Eliasson, L.7
Johnson, P.R.V.8
Renstrom, E.9
Schneider, T.10
Berggren, P.-O.11
Gopel, S.12
Ashcroft, F.M.13
Rorsman, P.14
-
27
-
-
0023820363
-
The order of islet microsvascular cellular perfusion is B → A → D in the perfused rat pancreas
-
Samols E, Stagner JI, Ewart RB, Marks V. The order of islet microvascular cellular perfusion is B→A→D in the perfused rat pancreas. J Clin Invest 1988;82:350-353 (Pubitemid 18262537)
-
(1988)
Journal of Clinical Investigation
, vol.82
, Issue.1
, pp. 350-353
-
-
Samols, E.1
Stagner, J.I.2
Ewart, R.B.L.3
Marks, V.4
-
28
-
-
0032765469
-
Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats
-
DOI 10.1054/npep.1999.0022
-
Adeghate E. Distribution of calcitonin-gene-related peptide, neuropeptide- Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats. Neuropeptides 1999;33:227-235 (Pubitemid 29398144)
-
(1999)
Neuropeptides
, vol.33
, Issue.3
, pp. 227-235
-
-
Adeghate, E.1
-
29
-
-
33144467088
-
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
-
DOI 10.1073/pnas.0510790103
-
Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 2006;103:2334-2339 (Pubitemid 43271670)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.7
, pp. 2334-2339
-
-
Cabrera, O.1
Berman, D.M.2
Kenyon, N.S.3
Ricordi, C.4
Berggren, P.-O.5
Caicedo, A.6
-
30
-
-
70450124317
-
Islet architecture: A comparative study
-
Kim A, Miller K, Jo J, Kilimnik G, Wojcik P, Hara M. Islet architecture: A comparative study. Islets 2009;1:129-136
-
(2009)
Islets
, vol.1
, pp. 129-136
-
-
Kim, A.1
Miller, K.2
Jo, J.3
Kilimnik, G.4
Wojcik, P.5
Hara, M.6
-
31
-
-
67650686039
-
Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells
-
Braun M, Ramracheya R, Amisten S, et al. Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009;52:1566-1578
-
(2009)
Diabetologia
, vol.52
, pp. 1566-1578
-
-
Braun, M.1
Ramracheya, R.2
Amisten, S.3
-
32
-
-
0036259920
-
Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses
-
Chan O, Chan S, Inouye K, Shum K, Matthews SG, Vranic M. Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses. Diabetes 2002;51:1681-1689 (Pubitemid 34564278)
-
(2002)
Diabetes
, vol.51
, Issue.6
, pp. 1681-1689
-
-
Chan, O.1
Chan, S.2
Inouye, K.3
Shum, K.4
Matthews, S.G.5
Vranic, M.6
-
33
-
-
0023789224
-
Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: Evidence for diminished hypothalamic-pituitary hormonal secretion
-
Frier BM, Fisher BM, Gray CE, Beastall GH. Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion. Diabetologia 1988;31:421-429
-
(1988)
Diabetologia
, vol.31
, pp. 421-429
-
-
Frier, B.M.1
Fisher, B.M.2
Gray, C.E.3
Beastall, G.H.4
-
34
-
-
0030059485
-
Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus
-
DOI 10.1210/jc.81.2.684
-
Kinsley BT, Simonson DC. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:684-691 (Pubitemid 26055685)
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.2
, pp. 684-691
-
-
Kinsley, B.T.1
Simonson, D.C.2
-
35
-
-
0021928946
-
Corticotropin-releasing factor: A physiologic regulator of adrenal epinephrine secretion
-
DOI 10.1016/0006-8993(85)91048-0
-
Brown MR, Fisher LA, Webb V, Vale WW, Rivier JE. Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion. Brain Res 1985;328:355-357 (Pubitemid 15135162)
-
(1985)
Brain Research
, vol.328
, Issue.2
, pp. 355-357
-
-
Brown, M.R.1
Fisher, L.A.2
Webb, V.3
-
36
-
-
0029042149
-
Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extra-adrenal, and malignant pheochromocytomas
-
Epelbaum J, Bertherat J, Prevost G, et al. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extra-adrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab 1995;80:1837-1844
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 1837-1844
-
-
Epelbaum, J.1
Bertherat, J.2
Prevost, G.3
-
37
-
-
29744444533
-
Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland
-
DOI 10.1055/s-2005-921092
-
Ueberberg B, Tourne H, Redmann A, et al. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm Metab Res 2005;37:722-728 (Pubitemid 43028072)
-
(2005)
Hormone and Metabolic Research
, vol.37
, Issue.12
, pp. 722-728
-
-
Ueberberg, B.1
Tourne, H.2
Redman, A.3
Walz, M.K.4
Schmid, K.W.5
Mann, K.6
Petersenn, S.7
-
38
-
-
0035449109
-
i2-dependent activation of calcineurin and depriming of secretory granules
-
DOI 10.1111/j.1469-7793.2001.00519.x
-
Gromada J, Høy M, Buschard K, Salehi A, Rorsman P. Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. J Physiol 2001;535:519-532 (Pubitemid 32825687)
-
(2001)
Journal of Physiology
, vol.535
, Issue.2
, pp. 519-532
-
-
Gromada, J.1
Hoy, M.2
Buschard, K.3
Salehi, A.4
Rorsman, P.5
-
39
-
-
0030967933
-
2+ channels
-
DOI 10.1085/jgp.110.3.217
-
Gromada J, Bokvist K, Ding WG, et al. Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol 1997; 110:217-228 (Pubitemid 27388115)
-
(1997)
Journal of General Physiology
, vol.110
, Issue.3
, pp. 217-228
-
-
Gromada, J.1
Bokvist, K.2
Ding, W.-G.3
Barg, S.4
Buschard, K.5
Renstrom, E.6
Rorsman, P.7
-
40
-
-
0033064018
-
+ channel
-
DOI 10.1016/S0014-5793(99)00076-9, PII S0014579399000769
-
Yoshimoto Y, Fukuyama Y, Horio Y, Inanobe A, Gotoh M, Kurachi Y. Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K+ channel. FEBS Lett 1999;444:265-269 (Pubitemid 29092815)
-
(1999)
FEBS Letters
, vol.444
, Issue.2-3
, pp. 265-269
-
-
Yoshimoto, Y.1
Fukuyama, Y.2
Horio, Y.3
Inanobe, A.4
Gotoh, M.5
Kurachi, Y.6
-
41
-
-
77956399106
-
GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- And L-type Ca2+ channel-dependent exocytosis
-
De Marinis YZ, Salehi A, Ward CE, et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab 2010;11:543-553
-
(2010)
Cell Metab
, vol.11
, pp. 543-553
-
-
De Marinis, Y.Z.1
Salehi, A.2
Ward, C.E.3
-
42
-
-
34047096301
-
Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells
-
Vieira E, Salehi A, Gylfe E. Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells. Diabetologia 2007;50:370-379
-
(2007)
Diabetologia
, vol.50
, pp. 370-379
-
-
Vieira, E.1
Salehi, A.2
Gylfe, E.3
-
43
-
-
34547112278
-
Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition
-
DOI 10.1210/en.2006-1659
-
Singh V, Grötzinger C, Nowak KW, et al. Somatostatin receptor subtype-2- deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition. Endocrinology 2007;148:3887-3899 (Pubitemid 47105850)
-
(2007)
Endocrinology
, vol.148
, Issue.8
, pp. 3887-3899
-
-
Singh, V.1
Grotzinger, C.2
Nowak, K.W.3
Zacharias, S.4
Goncz, E.5
Pless, G.6
Sauer, I.M.7
Eichhorn, I.8
Pfeiffer-Guglielmi, B.9
Hamprecht, B.10
Wiedenmann, B.11
Plockinger, U.12
Strowski, M.Z.13
|